User menu

Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.

Bibliographic reference Thwala, Lungile ; Préat, Véronique ; Csaba, Noémi Stefania. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.. In: Expert Opinion on Drug Delivery, , p. 1-14 (2016)
Permanent URL
  1. Tsomaia Natia, Peptide therapeutics: Targeting the undruggable space, 10.1016/j.ejmech.2015.01.014
  2. Ratnaparkhi MP, Int J Curr Pharm Res, 3, 1 (2011)
  3. Lassmann-Vague V., Raccah D., Alternatives routes of insulin delivery, 10.1016/s1262-3636(06)72804-x
  4. Sohi Harmik, Ahuja Alka, Ahmad Farhan Jalees, Khar Roop Krishen, Critical evaluation of permeation enhancers for oral mucosal drug delivery, 10.3109/03639040903117348
  5. Maisel Katharina, Ensign Laura, Reddy Mihika, Cone Richard, Hanes Justin, Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse, 10.1016/j.jconrel.2014.10.026
  6. Antunes Filipa, Andrade Fernanda, Araújo Francisca, Ferreira Domingos, Sarmento Bruno, Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs, 10.1016/j.ejpb.2012.10.003
  7. Iversen Tore-Geir, Skotland Tore, Sandvig Kirsten, Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies, 10.1016/j.nantod.2011.02.003
  8. Grover Gregory N, Maynard Heather D, Protein–polymer conjugates: synthetic approaches by controlled radical polymerizations and interesting applications, 10.1016/j.cbpa.2010.10.008
  9. Su Fang-Yi, Lin Kun-Ju, Sonaje Kiran, Wey Shiaw-Pyng, Yen Tzu-Chen, Ho Yi-Cheng, Panda Nilendu, Chuang Er-Yuan, Maiti Barnali, Sung Hsing-Wen, Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery, 10.1016/j.biomaterials.2011.12.038
  10. Tan Mei Lin, Choong P.F.M., Dass C.R., Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery, 10.1016/j.peptides.2009.10.002
  11. Maggio Edward T, Intravail™: highly effective intranasal delivery of peptide and protein drugs, 10.1517/17425247.3.4.529
  12. Ozsoy Yıldız, Gungor Sevgi, Cevher Erdal, Nasal Delivery of High Molecular Weight Drugs, 10.3390/molecules14093754
  13. Andrade Fernanda, Videira Mafalda, Ferreira Domingos, Sarmento Bruno, Nanocarriers for pulmonary administration of peptides and therapeutic proteins, 10.2217/nnm.10.143
  14. Ueno Hiroaki, Mizuta Masanari, Shiiya Tomomi, Tsuchimochi Wakaba, Noma Kenji, Nakashima Noboru, Fujihara Mitsuteru, Nakazato Masamitsu, Exploratory Trial of Intranasal Administration of Glucagon-Like Peptide-1 in Japanese Patients With Type 2 Diabetes: Figure 1, 10.2337/dc13-0690
  15. Rash Joshua A., Campbell Tavis S., The Effect of Intranasal Oxytocin Administration on Acute Cold Pressor Pain : A Placebo-Controlled, Double-Blind, Within-Participants Crossover Investigation, 10.1097/psy.0000000000000068
  16. Geho W. Blair, Geho Hans C., Lau John R., Gana Theophilus J., Hepatic-Directed Vesicle Insulin: A Review of Formulation Development and Preclinical Evaluation, 10.1177/193229680900300627
  17. Allon Dror M., Anavi Yakir, Calderon Shlomo, Central giant cell lesion of the jaw: Nonsurgical treatment with calcitonin nasal spray, 10.1016/j.tripleo.2009.02.013
  18. Djupesland Per Gisle, Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review, 10.1007/s13346-012-0108-9
  19. Patton John S., Mechanisms of macromolecule absorption by the lungs, 10.1016/0169-409x(95)00113-l
  20. Lombry Catherine, Bosquillon Cynthia, Préat Véronique, Vanbever Rita, Confocal imaging of rat lungs following intratracheal delivery of dry powders or solutions of fluorescent probes, 10.1016/s0168-3659(02)00174-8
  21. Uchenna Agu Remigius, Ikechukwu Ugwoke Michael, Armand Michoel, Kinget Renaat, Verbeke Norbert, 10.1186/rr58
  22. Kim D., Mudaliar S., Chinnapongse S., Chu N., Boies S. M., Davis T., Perera A. D., Fishman R. S., Shapiro D. A., Henry R., Dose-Response Relationships of Inhaled Insulin Delivered via the Aerodose Insulin Inhaler and Subcutaneously Injected Insulin in Patients With Type 2 Diabetes, 10.2337/diacare.26.10.2842
  23. Peters Reiner, From fluorescence nanoscopy to nanoscopic medicine, 10.2217/17435889.3.1.1
  24. Mara Mainardes Rubiana, Cristina Cocenza Urban Maria, Oliveira Cinto Priscila, Vinicius Chaud Marco, Cesar Evangelista Raul, Palmira Daflon Gremiao Maria, Liposomes and Micro/Nanoparticles as Colloidal Carriers for Nasal Drug Delivery, 10.2174/156720106777731019
  25. Ahmad A, Int J Diabetes Clin Res, 1 (2014)
  26. Singh Rajesh, Lillard James W., Nanoparticle-based targeted drug delivery, 10.1016/j.yexmp.2008.12.004
  27. Sosnik Alejandro, das Neves José, Sarmento Bruno, Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review, 10.1016/j.progpolymsci.2014.07.010
  28. Antosova Zuzana, Mackova Martina, Kral Vladimir, Macek Tomas, Therapeutic application of peptides and proteins: parenteral forever?, 10.1016/j.tibtech.2009.07.009
  29. Türker Selcan, Onur Erten, Ózer Yekta, Nasal route and drug delivery systems, 10.1023/b:phar.0000026823.82950.ff
  30. Binkley N., Bone H., Gilligan J. P., Krause D. S., Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial, 10.1007/s00198-014-2796-0
  31. Giustina Andrea, Karamouzis Ioannis, Patelli Ilaria, Mazziotti Gherardo, Octreotide for acromegaly treatment: a reappraisal, 10.1517/14656566.2013.847090
  32. Kaspar Allan A., Reichert Janice M., Future directions for peptide therapeutics development, 10.1016/j.drudis.2013.05.011
  33. Smart Alice L, Gaisford Simon, Basit Abdul W, Oral peptide and protein delivery: intestinal obstacles and commercial prospects, 10.1517/17425247.2014.917077
  34. Choonara Bibi F., Choonara Yahya E., Kumar Pradeep, Bijukumar Divya, du Toit Lisa C., Pillay Viness, A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules, 10.1016/j.biotechadv.2014.07.006
  35. Sabetsky Vladimir, Ekblom Jonas, Insulin: A new era for an old hormone☆, 10.1016/j.phrs.2009.07.010
  36. Zijlstra Eric, Heinemann Lutz, Plum-Mörschel Leona, Oral Insulin Reloaded : A Structured Approach, 10.1177/1932296814529988
  37. Clement Stephen, Still J. Gordon, Kosutic Gordana, McAllister R.G., Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2, 10.1089/152091502760306544
  38. Sikiric P., Seiwerth S., Brcic L., Blagaic A. B., Zoricic I., Sever M., Klicek R., Radic B., Keller N., Sipos K., Jakir A., Udovicic M., Tonkic A., Kokic N., Turkovic B., Mise S., Anic T., Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response., 10.1007/s10787-006-1531-7
  39. Caon Thiago, Jin Liang, Simões Cláudia M. O., Norton Raymond S., Nicolazzo Joseph A., Enhancing the Buccal Mucosal Delivery of Peptide and Protein Therapeutics, 10.1007/s11095-014-1485-1
  40. Heinemann Lutz, Jacques Yves, Oral Insulin and Buccal Insulin: A Critical Reappraisal, 10.1177/193229680900300323
  41. Fosgerau Keld, Hoffmann Torsten, Peptide therapeutics: current status and future directions, 10.1016/j.drudis.2014.10.003
  42. Traverso Giovanni, Schoellhammer Carl M., Schroeder Avi, Maa Ruby, Lauwers Gregory Y., Polat Baris E., Anderson Daniel G., Blankschtein Daniel, Langer Robert, Microneedles for Drug Delivery via the Gastrointestinal Tract, 10.1002/jps.24182
  43. Chalasani Kishore B., Russell-Jones Gregory J., Jain Akhlesh K., Diwan Prakash V., Jain Sanjay K., Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles, 10.1016/j.jconrel.2007.05.019